Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Relmada Therapeutics Inc
(NQ:
RLMD
)
2.800
+0.030 (+1.08%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Relmada Therapeutics Inc
< Previous
1
2
3
4
Next >
RLMD Stock Earnings: Relmada Therapeutics Beats EPS for Q2 2024
August 07, 2024
RLMD stock results show that Relmada Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Keurig Dr Pepper To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday
June 05, 2024
Via
Benzinga
7 Penny Biotech Stocks to Triple Your Investment
May 28, 2024
Biotech penny stocks offer the chance to triple your investments and require an appetite for risk in order to capture returns.
Via
InvestorPlace
RLMD Stock Earnings: Relmada Therapeutics Beats EPS for Q1 2024
May 08, 2024
RLMD stock results show that Relmada Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
RLMD Stock Earnings: Relmada Therapeutics Misses EPS for Q4 2023
March 19, 2024
RLMD stock results show that Relmada Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Recap: Relmada Therapeutics Q4 Earnings
March 19, 2024
Via
Benzinga
Earnings Outlook For Relmada Therapeutics
March 18, 2024
Via
Benzinga
Earnings Outlook For Relmada Therapeutics
November 07, 2023
Via
Benzinga
Relmada Therapeutics: Q1 Earnings Insights
May 11, 2023
Via
Benzinga
Earnings Preview For Relmada Therapeutics
May 10, 2023
Via
Benzinga
Earnings Scheduled For March 19, 2024
March 19, 2024
Companies Reporting Before The Bell • Tencent Music Enter Gr (NYSE:TME) is projected to report quarterly earnings at $0.14 per share on revenue of $931.97 million.
Via
Benzinga
Relmada Therapeutics And 2 Other Penny Stocks Insiders Are Buying
February 01, 2024
The Dow Jones index closed lower by more than 300 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
January 04, 2024
Shares of Mobileye Global Inc. (NASDAQ: MBLY) fell sharply during Thursday’s session after the company issued preliminary FY23 financial results and initial 2024 guidance.<
Via
Benzinga
Preview: Relmada Therapeutics's Earnings
March 22, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
January 04, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
October 04, 2023
We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Wednesday.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
September 21, 2023
Via
Benzinga
Relmada Therapeutics' Lead Candidate Shows Promise In Pivotal Depression Study
September 20, 2023
Relmada Therapeutics Inc (NASDAQ: RLMD) announced efficacy results for the de novo (or new to treatment) patients (204 patients) and safety results for all subjects (627 patients) from the Phase 3...
Via
Benzinga
FDA's Rejection of Sage/Biogen's Zuranolone Boosts Prospects for Axsome's Auvelity, Analyst Says
August 07, 2023
Axsome Therapeutics Inc (NASDAQ: AXSM) reported Q2 sales of $46.7 million, beating the consensus of $40.19 million.
Via
Benzinga
7 Healthcare Stocks to Ditch Before They Make Your Portfolio Sick
July 31, 2023
For investors who choose wisely, profits in healthcare stocks can be spectacular. But the losses can also be dramatic if you choose poorly.
Via
InvestorPlace
Earnings Scheduled For May 11, 2023
May 11, 2023
Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings for its fourth quarter. • Exela Technologies (NASDAQ:XELA) is expected to report earnings for its...
Via
Benzinga
Earnings Scheduled For March 23, 2023
March 23, 2023
Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is likely to report earnings for its fourth quarter.
Via
Benzinga
Vistagen Poised To Begin Phase 1 Trial Of A Fast-Acting Antidepressant Nasal Spray In First Quarter Of 2023
January 17, 2023
In the race to create faster-acting, safer antidepressants, Vistagen (NASDAQ: VTGN) is starting the year strong as it gets ready to launch a Phase 1 Trial of its novel pherine nasal spray for Major...
Via
Benzinga
Looking Into Relmada Therapeutics's Recent Short Interest
January 03, 2023
Relmada Therapeutics's (NASDAQ:RLMD) short percent of float has fallen 13.6% since its last report. The company recently reported that it has 1.72 million shares sold short, which is 5.78% of all...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 29, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 28, 2022
Via
Benzinga
Relmada Therapeutics And 2 Other Penny Stocks Insiders Are Aggressively Buying
December 13, 2022
The Dow Jones closed higher by over 500 points on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
December 12, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
December 09, 2022
Via
Benzinga
Looking Into Relmada Therapeutics's Recent Short Interest
December 09, 2022
Relmada Therapeutics's (NASDAQ:RLMD) short percent of float has fallen 8.99% since its last report. The company recently reported that it has 2.77 million shares sold short, which is 9.31% of all...
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.